|
Cardio-Oncology for the HF Boards
|
Review the cardiovascular complications associated with cancer therapies, including chemotherapy- and radiation-induced cardiotoxicity. This session focuses on risk assessment, surveillance strategies, prevention, and management of heart failure in patients with cancer, highlighting key concepts frequently tested on the AHFTC Board Certification Examination.
|
|
Clinico-Pathologic Correlates in Heart Failure / Images for the Heart Failure Boards
|
Strengthen your diagnostic skills through a review of pathology, imaging, electrocardiograms, hemodynamic tracings, and clinical case correlations. Learn to recognize classic board-style images and integrate clinical findings to arrive at the correct diagnosis.
|
|
Diabetes Mellitus (DM), Obesity, and CKM Syndrome
|
Explore the complex relationship between diabetes, obesity, chronic kidney disease, and cardiovascular disease. Review the pathophysiology of Cardiovascular-Kidney-Metabolic (CKM) Syndrome, current guideline-directed therapies, and multidisciplinary management strategies relevant to contemporary heart failure care.
|
|
Diagnosis and Clinical Assessment
|
Review the essential components of heart failure diagnosis, including history, physical examination, laboratory testing, imaging, biomarkers, and functional assessment. Emphasis is placed on developing a systematic approach to evaluating patients across the spectrum of heart failure.
|
|
Healthcare Disparities in Heart Failure
|
Examine the social, economic, racial, ethnic, and geographic factors that contribute to disparities in heart failure prevention, diagnosis, treatment, and outcomes. Learn strategies to improve health equity and deliver culturally responsive, patient-centered care.
|
|
Heart Failure Epidemiology and Risk Factors
|
Review the epidemiology of heart failure, including disease prevalence, incidence, morbidity, mortality, and healthcare burden. Discuss modifiable and non-modifiable risk factors, prevention strategies, and population trends that influence disease development and progression.
|
|
Hemodynamics in Heart Failure (Virtual)
|
Develop a practical understanding of cardiovascular hemodynamics through interpretation of pressure tracings, cardiac output measurements, and invasive monitoring data. Learn how hemodynamic principles guide diagnosis, treatment decisions, and advanced heart failure management.
|
|
Issues in Chronic Heart Failure Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)
|
Review comprehensive outpatient management strategies for chronic heart failure, including the clinical application of biomarkers, remote patient monitoring technologies, exercise and dietary interventions, patient education, and strategies to reduce hospitalizations while improving quality of life.
|
|
Management of Comorbidities in Heart Failure – Sleep Disorders
|
Examine the impact of sleep disorders, including obstructive and central sleep apnea, on heart failure outcomes. Review diagnostic approaches, evidence-based treatment options, and the role of sleep management in comprehensive heart failure care.
|
|
Optimal Medical Therapy for HFrEF (Virtual)
|
Review guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF), including the foundational medication classes, treatment sequencing, dose optimization, and management of common adverse effects. This session reinforces evidence-based pharmacologic management essential for board preparation.
|
|
Pathophysiology 1: Cellular and Energetic Considerations
|
Explore the cellular mechanisms underlying heart failure, including myocardial metabolism, mitochondrial dysfunction, calcium handling, oxidative stress, inflammation, and myocardial remodeling. Gain a deeper understanding of disease mechanisms that form the foundation for current therapies.
|
|
Pathophysiology 2: Hemodynamic, Structural, and Neurohormonal Considerations
|
Build upon the cellular basis of heart failure by reviewing ventricular remodeling, pressure-volume relationships, neurohormonal activation, ventricular dysfunction, and compensatory mechanisms that contribute to disease progression and therapeutic targets.
|
|
Pulmonary Hypertension – Classification and Initial Evaluation
|
Review the classification of pulmonary hypertension, diagnostic criteria, and recommended evaluation strategies. Learn to differentiate pulmonary hypertension subtypes and recognize the relationship between pulmonary hypertension and heart failure.
|
|
Pulmonary Hypertension – Treatment
|
Examine evidence-based treatment approaches for pulmonary hypertension, including pharmacologic therapies, patient selection, referral considerations, and management strategies for pulmonary hypertension associated with left-sided heart disease and other etiologies.
|
|
RV Failure and Tricuspid Regurgitation (TR) Management
|
Review the causes, pathophysiology, diagnosis, and management of right ventricular failure and tricuspid regurgitation. Discuss medical therapy, hemodynamic optimization, imaging assessment, and evolving transcatheter and surgical treatment options.
|
|
Statistics for the HF Board
|
Refresh fundamental biostatistics and clinical research concepts commonly encountered on the AHFTC Board Certification Examination. Topics include study design, hypothesis testing, confidence intervals, sensitivity, specificity, predictive values, relative risk, hazard ratios, and interpretation of clinical trial results.
|